These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3496904)

  • 1. 17th forum in immunology: Molecular mechanisms of T-cell-mediated cytotoxicity.
    Ann Inst Pasteur Immunol; 1987; 138(2):289-342. PubMed ID: 3496904
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual mechanisms of lymphocyte-mediated cytotoxicity serve to control and deliver the immune response.
    Smyth MJ
    Bioessays; 1995 Oct; 17(10):891-8. PubMed ID: 7487970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for CD28-dependent T cell-mediated cytotoxicity.
    Azuma M; Cayabyab M; Phillips JH; Lanier LL
    J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ovalbumin peptide-specific cytotoxic T cell clone with antigen self-presentation capacity uses two distinct mechanisms to kill target cells.
    Dick T; Reichmann G; Ebnet K; Simon MM; Dienes HP; Echternacher B; Krammer PH; Reske-Kunz AB
    Cell Immunol; 1993 Dec; 152(2):333-47. PubMed ID: 8258142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
    Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
    J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
    Frost P; Ng CP; Belldegrun A; Bonavida B
    Cell Immunol; 1997 Aug; 180(1):70-83. PubMed ID: 9316641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lectin-dependent T cell-mediated cytotoxicity against Hep-2 cells.
    Perl A; Pócsik E; Gonzalez-Cabello R; Láng I; Gergely P
    Acta Physiol Hung; 1983; 61(4):225-31. PubMed ID: 6606296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell mediated cytotoxic activities in ataxia-telangiectasia with T cell deficiency].
    Tsuge I; Matsuoka H; Okada J; Mizuno T; Matsuoka M; Torii S; Kodera Y; Takahashi T
    Arerugi; 1984 Oct; 33(10):909-16. PubMed ID: 6335392
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
    Huang Y; Shah S; Qiao L
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell-mediated cytotoxicity].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1982 Dec; 62(12):747-52. PubMed ID: 6820326
    [No Abstract]   [Full Text] [Related]  

  • 12. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.
    Olsson B; Andersson PO; Jernås M; Jacobsson S; Carlsson B; Carlsson LM; Wadenvik H
    Nat Med; 2003 Sep; 9(9):1123-4. PubMed ID: 12937414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity. An overview.
    Burakoff SJ
    Fed Proc; 1984 Feb; 43(2):266-7. PubMed ID: 6420197
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer.
    Kershaw MH; Trapani JA; Smyth MJ
    Ther Immunol; 1995 Jun; 2(3):173-81. PubMed ID: 8885135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reorientation of the Golgi apparatus and the microtubule-organizing center in the cytotoxic effector cell is a prerequisite in the lysis of bound target cells.
    Kupfer A; Dennert G; Singer SJ
    J Mol Cell Immunol; 1985; 2(1):37-49. PubMed ID: 3880506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
    Lieberman J
    Nat Rev Immunol; 2003 May; 3(5):361-70. PubMed ID: 12766758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target cell lysis: ultrastructural and cytoskeletal alterations.
    Leopardi E; Friend DS; Rosenau W
    J Immunol; 1984 Dec; 133(6):3429-36. PubMed ID: 6333460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.